The Hospital del Salvador is a hospital in central Santiago, Chile. The hospital is located in the commune of Providencia.

During the past decade, Hospital del Salvador conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 7 clinical trials were completed, i.e. on average, 116.7% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 2 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital del Salvador" #1 sponsor was "Mannkind Corporation" with 3 trials, followed by "Pfizer" with 3 trials sponsored, "Levita Magnetics" with 2 trials sponsored, "Astellas Pharma Inc" with 1 trials sponsored and "Cogentus Pharmaceuticals" with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital del Salvador" #1 collaborator was "Hospital del Salvador" with 2 trials as a collaborator, "Amgen" with 1 trials as a collaborator, "Basilea Pharmaceutica" with 1 trials as a collaborator, "Clinica Alemana de Santiago" with 1 trials as a collaborator and "Clínica BUPA" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Hospital del Salvador" are "Acute Coronary Syndrome" (1 trials), "Alzheimer's Disease" (1 trials), "Arthritis, Rheumatoid" (1 trials), "Benign Gallbladder Disease" (1 trials) and "Candidemia" (1 trials). Many other conditions were trialed in "Hospital del Salvador" in a lesser frequency.

Most popular intervention types in "Hospital del Salvador" are "Drug" (11 trials), "Device" (2 trials), "Biological" (1 trials), "Combination Product" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Technosphere Insulin" (2 trials), "70% insulin aspart protamine suspension and 30% insulin aspart injection (rDNA origin)" (1 trials), "Active comparator" (1 trials) and "Asacol" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital del Salvador" are 16 trials for "All" genders.

Currently, there are NaN active trials in "Hospital del Salvador". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Hospital del Salvador, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital del Salvador, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".